EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of ( E )‐ N ’‐Benzylidenepyrazine‐2‐Carbohydrazides and their Derivatives

Priam-Amedeo Houngbedji iD, Daria Elżbieta Nawrot iD, Ondřej Janďourek iD, Klára Konečná iD, Martin Novák iD, Pavla Paterová iD, Pavel Bárta iD, Martina Hrast Rambaher iD, Eva Novotná, Carlo Castellano iD, Matteo Mori iD, Fiorella Meneghetti iD und 3 weitere

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Priam-Amedeo Houngbedji und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy in Hradec Králové, Charles University, Ak. Heyrovského 1203, 500 03, Hradec Králové, Czech Republic. Hauptthemen laut MEDLINE: Hydrazines, Antitubercular Agents, Pyrazines, Antineoplastic Agents. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union - Next Generation EU - National Institute of Virology and Bacteriology, Grant Agency of Charles University, University Hospital Hradec Kralove.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 33 ( E )‐ N ’‐benzylidenepyrazine‐2‐carbohydrazides and their derivatives were synthesized and tested for biological activity. Benzylidene derivatives with 2‐OH substitution on the phenyl ring ( 18 : R = 2‐OH, 21 : R = 2,3‐diOH, and 22 : R = 2,4‐diOH) exhibit various biological activities. Compounds 18 and 21 demonstrate antimycobacterial activity against Mycobacterium tuberculosis H37Ra, M. tuberculosis H37Rv, and M. aurum, with minimum inhibitory concentration values ranging from 15.625 to 62.5 μg mL −1 . Compounds 18 , 21 , and 22 show mild cytotoxicity on several human cell lines (IC 50 ranging from 70.2 to 500 μM). Crystallographic studies confirm the ( E )‐configuration of compound 18 and a nearly planar molecular conformation. Due to their structural similarity with salicylaldehyde isonicotinoyl hydrazone (SIH), a known iron chelator, selected compounds were tested for iron‐chelating properties, revealing comparable or superior activity. Mechanistic assays targeting enoyl‐[acyl carrier protein] reductase (InhA), isocitrate lyase (ICL), and lipid/mycolic acid biosynthesis show no significant inhibition, suggesting a nonspecific mechanism potentially linked to iron chelation. A correlation is observed between chelating activity and cytotoxicity, while antimycobacterial activity appears to involve additional mechanisms. Pharmacokinetic studies with compound 18 reveal no specific plasma metabolites, and no significant metabolites are detected after incubation with human liver microsomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrazinesAntitubercular AgentsPyrazinesAntineoplastic AgentsAnti-Bacterial AgentsHumansStructure-Activity RelationshipMicrobial Sensitivity TestsCell ProliferationMycobacterium tuberculosisMolecular StructureDose-Response Relationship, DrugDrug Screening Assays, AntitumorCell Line, Tumor

Stichwörter der Autor:innen

antimycobacterialsantitumor agentsiron chelatorsmedicinal chemistrypyrazine‐2‐carbohydrazides

Substanzen

HydrazinesAntitubercular AgentsPyrazinesAntineoplastic AgentsAnti-Bacterial Agentscarbohydrazide

Autor:innen und Institutionen

  • Faculty of Pharmacy in Hradec Králové, Charles University, Ak. Heyrovského 1203, 500 03, Hradec Králové, Czech Republic.
  • Biomedical Research Centre, University Hospital Hradec Králové, Sokolská 581, 500 05, Hradec Králové, Czech Republic.
  • Department of Clinical Microbiology, University Hospital Hradec Králové, Sokolská 581, 500 05, Hradec Králové, Czech Republic.
  • Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, SI-1000, Ljubljana, Slovenia.
  • Department of Chemistry, University of Milan, Via Golgi 19, 20133, Milan, Italy.
  • Department of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, 20133, Milan, Italy.

ORCID-Profile: Priam-Amedeo Houngbedji, Daria Elżbieta Nawrot, Ondřej Janďourek, Klára Konečná, Martin Novák, Pavla Paterová, Pavel Bárta, Martina Hrast Rambaher, Carlo Castellano, Matteo Mori, Fiorella Meneghetti, Monika Záhorszká, Jana Korduláková, Jan Zitko

Förderung

  • European Union - Next Generation EU - National Institute of Virology and Bacteriology
  • Grant Agency of Charles University
  • University Hospital Hradec Kralove
  • Charles University

Zitieren

APA

Houngbedji, P. A., Nawrot, D. E., Janďourek, O., Konečná, K., Novák, M., Paterová, P., Bárta, P., Rambaher, M. H., Novotná, E., Castellano, C., Mori, M., Meneghetti, F., Záhorszká, M., Korduláková, J., & Zitko, J. (2025). Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of ( E )‐ N ’‐Benzylidenepyrazine‐2‐Carbohydrazides and their Derivatives. ChemMedChem. https://doi.org/10.1002/cmdc.202500085

Vancouver

Houngbedji PA, Nawrot DE, Janďourek O, Konečná K, Novák M, Paterová P, et al. Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of ( E )‐ N ’‐Benzylidenepyrazine‐2‐Carbohydrazides and their Derivatives. ChemMedChem. 2025. doi:10.1002/cmdc.202500085

BibTeX
@article{Houngbedji2025,
  author = {Houngbedji, Priam-Amedeo and Nawrot, Daria Elżbieta and Janďourek, Ondřej and Konečná, Klára and Novák, Martin and Paterová, Pavla and Bárta, Pavel and Rambaher, Martina Hrast and Novotná, Eva and Castellano, Carlo and Mori, Matteo and Meneghetti, Fiorella and Záhorszká, Monika and Korduláková, Jana and Zitko, Jan},
  title = {Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of ( E )‐ N ’‐Benzylidenepyrazine‐2‐Carbohydrazides and their Derivatives},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500085}
}
Kostenlos starten →